p.97 抽出テキスト
Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2019;20: 1075–1093. https://doi.org/10.1093/ehjci/jez178 72. Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O, et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy–an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2017;18:237–253. https://doi.org/10.1093/ ehjci/jew229 73. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16: 233–270. https://doi.org/10.1093/ehjci/jev014 74. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013;14:721–740. https://doi.org/10.1093/ehjci/jet123 75. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010;31:2715–2726. https://doi.org/10.1093/eurheartj/ehq271 76. Liu D, Hu K, Nordbeck P, Ertl G, Störk S, Weidemann F. Longitudinal strain bull’s eye plot patterns in patients with cardiomyopathy and concentric left ventricular hypertrophy. Eur J Med Res 2016;21:21. https://doi.org/10.1186/s40001-016-0216-y 77. Haugaa KH, Hasselberg NE, Edvardsen T. Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. JACC Cardiovasc Imaging 2015;8:104–106. https://doi.org/10.1016/j.jcmg.2014.04.029 78. Haugaa KH, Goebel B, Dahlslett T, Meyer K, Jung C, Lauten A, et al. Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography. J Am Soc Echocardiogr 2012;25:667–673. https://doi.org/10.1016/j. echo.2012.02.004 79. Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH. Combination of ECG and echocardiography for identification of arrhythmic events in early ARVC. JACC Cardiovasc Imaging 2017;10:503–513. https://doi.org/10.1016/j.jcmg.2016.06.011 80. Haland TF, Almaas VM, Hasselberg NE, Saberniak J, Leren IS, Hopp E, et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016;17:613–621. https://doi.org/10.1093/ ehjci/jew005 81. Norrish G, Ding T, Field E, Ziolkowska L, Olivotto I, Limongelli G, et al. Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids). JAMA Cardiol 2019;4:918–927. https://doi.org/10. 1001/jamacardio.2019.2861 82. Lopez L, Frommelt PC, Colan SD, Trachtenberg FL, Gongwer R, Stylianou M, et al. Pediatric heart network echocardiographic Z scores: comparison with other published models. J Am Soc Echocardiogr 2021;34:185–192. https://doi.org/10.1016/j.echo.2020. 09.019 83. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol 2006;98:1507–1511. https://doi.org/10.1016/j. amjcard.2006.07.029 84. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699–1708. https://doi.org/10.1016/0735-1097(95)00390-8 85. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983;2: 437–444. https://doi.org/10.1016/S0735-1097(83)80269-1 86. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295–303. https://doi.org/10.1056/NEJMoa021332 87. Nistri S, Olivotto I, Betocchi S, Losi MA, Valsecchi G, Pinamonti B, et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am J Cardiol 2006;98:960–965. https://doi.org/10.1016/j.amjcard.2006.05.013 88. Debonnaire P, Joyce E, Hiemstra Y, Mertens BJ, Atsma DE, Schalij MJ, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation. Circ Arrhythm Electrophysiol 2017;10:e004052. https://doi.org/10.1161/ CIRCEP.116.004052 89. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the endstage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216–225. https:// doi.org/10.1161/CIRCULATIONAHA.105.583500 90. Alba AC, Gaztanaga J, Foroutan F, Thavendiranathan P, Merlo M, Alonso-Rodriguez D, et al. Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR group. Circ Cardiovasc Imaging 2020;13:e010105. https://doi.org/10. 1161/CIRCIMAGING.119.010105 91. Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, et al. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in newpresentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography. Eur Heart J 2012;33:640–648. https://doi.org/10. 1093/eurheartj/ehr391 92. Yoerger DM, Marcus F, Sherrill D, Calkins H, Towbin JA, Zareba W, et al. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol 2005;45:860–865. https://doi.org/10.1016/j.jacc. 2004.10.070 93. Pieles GE, Grosse-Wortmann L, Hader M, Fatah M, Chungsomprasong P, Slorach C, et al. Association of echocardiographic parameters of right ventricular remodeling and myocardial performance with modified task force criteria in adolescents with arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Imaging 2019;12:e007693. https://doi.org/10.1161/CIRCIMAGING.118.007693 94. Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008;133:1426–1435. https://doi.org/10.1378/chest.07-2784 95. Skold CM, Larsen FF, Rasmussen E, Pehrsson SK, Eklund AG. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med 2002;252:465–471. https://doi.org/10.1046/j.1365-2796.2002. 01058.x 96. Joyce E, Ninaber MK, Katsanos S, Debonnaire P, Kamperidis V, Bax JJ, et al. Subclinical left ventricular dysfunction by echocardiographic speckle–tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail 2015;17:51–62. https://doi.org/10. 1002/ejhf.205 97. Pagourelias ED, Mirea O, Duchenne J, Van Cleemput J, Delforge M, Bogaert J, et al. Echo parameters for differential diagnosis in cardiac amyloidosis: a head-to-head comparison of deformation and nondeformation parameters. Circ Cardiovasc Imaging 2017; 10:e005588. https://doi.org/10.1161/CIRCIMAGING.116.005588 98. Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012;98:1442–1448. https://doi.org/10.1136/heartjnl-2012-302353 99. Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, et al. Cardiac manifestations of Anderson–Fabry disease: results from the international Fabry outcome survey. Eur Heart J 2007;28:1228–1235. https://doi.org/10.1093/ eurheartj/ehm153 100. Boldrini M, Cappelli F, Chacko L, Restrepo-Cordoba MA, Lopez-Sainz A, Giannoni A, et al. Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2020;13:909–920. https://doi.org/10.1016/j.jcmg.2019. 10.011 101. Pieroni M, Chimenti C, De Cobelli F, Morgante E, Del Maschio A, Gaudio C, et al. Fabry’s disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 2006;47:1663–1671. https:// doi.org/10.1016/j.jacc.2005.11.070 102. Zemrak F, Ahlman MA, Captur G, Mohiddin SA, Kawel-Boehm N, Prince MR, et al. The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. J Am Coll Cardiol 2014;64:1971–1980. https://doi. org/10.1016/j.jacc.2014.08.035 103. Steeden JA, Quail M, Gotschy A, Mortensen KH, Hauptmann A, Arridge S, et al. Rapid whole-heart CMR with single volume super-resolution. J Cardiovasc Magn Reson 2020; 22:56. https://doi.org/10.1186/s12968-020-00651-x 104. Kiblboeck D, Reiter C, Kammler J, Schmit P, Blessberger H, Kellermair J, et al. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. J Cardiovasc Magn Reson 2018;20:47. https://doi.org/10. 1186/s12968-018-0469-4 105. Rajiah P, Kay F, Bolen M, Patel AR, Landeras L. Cardiac magnetic resonance in patients with cardiac implantable electronic devices: challenges and solutions. J Thorac Imaging 2020;35:W1–W17. https://doi.org/10.1097/RTI.0000000000000462 106. Gandjbakhch E, Dacher JN, Taieb J, Chauvin M, Anselme F, Bartoli A, et al. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices. Arch Cardiovasc Dis 2020;113:473–484. 107. Nazarian S, Hansford R, Rahsepar AA, Weltin V, McVeigh D, Gucuk Ipek E, et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med 2017;377: 2555–2564. https://doi.org/10.1056/NEJMoa1604267 108. Russo RJ, Costa HS, Silva PD, Anderson JL, Arshad A, Biederman RW, et al. Assessing the risks associated with MRI in patients with a pacemaker or defibrillator. N Engl J Med 2017;376:755–764. https://doi.org/10.1056/NEJMoa1603265 109. Gakenheimer-Smith L, Etheridge SP, Niu MC, Ou Z, Presson AP, Whitaker P, et al. MRI in pediatric and congenital heart disease patients with CIEDs and epicardial or abandoned leads. Pacing Clin Electrophysiol 2020;43:797–804. https://doi.org/10.1111/ pace.13984 ESC Guidelines 3599 Downloaded from academic.oup.com/eurheartj/article/44/37/3503/7246608 by guest on 07 October 2026